UC DAVIS SUPERFUND RESEARCH PROGRAM Superfund sites are diverse, and many include unknown chemicals, chemicals of unknown toxicity and/or toxic degradation products. Currently, methods to detect, prioritize, and remediate these chemicals are incomplete or nonexistent. The UC Davis Superfund Research Center (UCD-SRC) will conduct research to: (i) improve understanding of the mechanisms by which hazardous chemicals produce adverse health effects, (ii) develop, validate and integrate novel methods to evaluate chemical exposures, levels of contamination, and health risks, and (iii) develop innovative remediation strategies to reduce hazardous substance exposure and toxicity. To achieve these goals the SRC consists of 5 integrated projects, 2 research support cores, a training core, a community engagement core, a research translation core and an administrative core. The UCD-SRC will use integrated chromatographic, biosensor and cell based technologies to detect and identify contaminants and develop innovative approaches for bioremediation. Rapid immunochemical and cell based analysis will supplement classical technologies for the evaluation of sites, as well as determining human susceptibility, exposure and effect. Fundamental mechanisms of toxic action of selected chemicals will be explored to predict risk and develop new biomarkers. This mechanistic knowledge will be extended in vivo with an emphasis on mechanism of toxicity. We are expanding the use of transcriptomics, proteomics, metabolomics and integrated bioinformatics technologies to discover new mechanisms of action of hazardous materials and biomarkers for their action and to connect hazardous substance exposures to organism level effects. The biomarkers developed in this project will serve as biological dosimeters in exposure studies. All aspects of the program will be connected to our Community Engagement Core, and subject to community approval will be demonstrated on Yurok Tribal Lands. Technologies developed by the SRC will be tested at field sites and transferred to end users through a research translation core. Program Relevance We will develop sensitive systems for evaluating and mitigating the risk of hazardous chemicals on human populations and the environment using biomarkers of both exposure and effect.

Public Health Relevance

UC DAVIS SUPERFUND RESEARCH PROGRAM The UC Davis Superfund Research Center conducts research to: (i) improve understanding of the mechanisms by which hazardous chemicals produce adverse health effects, (b) develop, validate and integrate novel methods to evaluate chemical exposures, levels of contamination, and health risks, and (c) develops innovative remediation strategies to reduce hazardous substance exposure and toxicity. These activities will improve the ability of the National Superfund Program to address legacy and emerging contaminants and associated transformation products to more comprehensively protect the U.S. population from health risks posed by hazardous substances.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
5P42ES004699-30
Application #
9543281
Study Section
Special Emphasis Panel (ZES1)
Program Officer
Henry, Heather F
Project Start
1997-04-01
Project End
2022-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
30
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Davis
Department
Zoology
Type
Earth Sciences/Resources
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Harris, Todd R; Kodani, Sean; Rand, Amy A et al. (2018) Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury. Mol Pharmacol 94:834-841
Bever, Candace S; Rand, Amy A; Nording, Malin et al. (2018) Effects of triclosan in breast milk on the infant fecal microbiome. Chemosphere 203:467-473
Zheng, Jing; McKinnie, Shaun M K; El Gamal, Abrahim et al. (2018) Organohalogens Naturally Biosynthesized in Marine Environments and Produced as Disinfection Byproducts Alter Sarco/Endoplasmic Reticulum Ca2+ Dynamics. Environ Sci Technol 52:5469-5478
Lakkappa, Navya; Krishnamurthy, Praveen T; Yamjala, Karthik et al. (2018) Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development. J Pharm Biomed Anal 149:457-464
Guedes, A G P; Aristizabal, F; Sole, A et al. (2018) Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis. J Vet Pharmacol Ther 41:230-238
Heikenfeld, J; Jajack, A; Rogers, J et al. (2018) Wearable sensors: modalities, challenges, and prospects. Lab Chip 18:217-248
Minaz, Nathani; Razdan, Rema; Hammock, Bruce D et al. (2018) An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. Prostaglandins Other Lipid Mediat 136:84-89
Lassabe, Gabriel; Kramer, Karl; Hammock, Bruce D et al. (2018) Noncompetitive Homogeneous Detection of Small Molecules Using Synthetic Nanopeptamer-Based Luminescent Oxygen Channeling. Anal Chem 90:6187-6192
?ertíková Chábová, V?ra; Kujal, Petr; Škaroupková, Petra et al. (2018) Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Kidney Blood Press Res 43:329-349
Kodani, Sean D; Bhakta, Saavan; Hwang, Sung Hee et al. (2018) Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Bioorg Med Chem Lett 28:762-768

Showing the most recent 10 out of 1149 publications